News

Categories

November 4, 2025

Zymeworks Presents New Preclinical Data at the Society for Immunotherapy of Cancer Conference

October 16, 2025

Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

October 13, 2025

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

October 7, 2025

Zymeworks Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer Annual Meeting

September 26, 2025

Zymeworks Presents Preclinical Data on ZW1528 at the European Respiratory Society Annual Congress

September 15, 2025

Zymeworks Announces Presentation at the European Respiratory Society (ERS) Congress 2025

July 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

July 10, 2025

Zymeworks Wins Life Sciences BC 2025 Company of the Year Award

April 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

April 21, 2025

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

April 17, 2025

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

April 10, 2025

Zymeworks to Present at the AACR Oncology Industry Partnering Event